Bizarre Science: Sexually Frustrated Flies Are Driven to Drink

When she says no, the bottle beckons more brightly for men and for fruit flies, according to a new study that found that male flies that had been repeatedly spurned by females were more likely to turn to alcohol to self-medicate their frustration.

As a topic of study, drunk fruit flies may seem trifling, but what the findings reveal about the neurochemistry that drives behaviors like sex and eating may point the way to new drugs to fight both addiction and obesity.

Researchers performed several clever experiments to determine the relationship between sexual frustration and drinking in male flies. Some lucky males were allowed four days of mating for six-hour sessions at a time (each bout of fruit fly copulation takes 20 minutes) with an abundance of sexually receptive females the female-to-male ratio was a satisfying 5-to-1. The male flies were housed either together or alone.

The unlucky experimental group was introduced to females that had already mated and had no desire to mate again. The females ran away, kicked and stuck out their egg-laying organ to fend males off. The male flies underwent this exercise in sexual frustration and rejection three times a day, for an hour at a time, over four days. Again, some of the males were kept in containers with other male flies, while others were isolated.

A third group of males was exposed to the sad sight of decapitated virgin females a situation that resulted in sexual frustration, but no active rejection.

MORE: Do Monkeys Pay for Sex?

After these experiences, the flies were given a choice of ordinary food (yeast and sugar) or food that had been spiked with the kick of 30-proof spirits (yeast, sugar and 15% alcohol). Not surprisingly, the sexually rejected flies boozed much more than the mated group with those males that had been spurned and alone hitting the sauce the hardest. The flies that had been sexually frustrated but not rejected also drank more than those that had been allowed to mate. However, when flies that had first been rejected were later given a chance to mate, their extra preference for alcohol disappeared.

So what was going on in the flies brains? Researchers found that a neurotransmitter called neuropeptide F, or NPF, which seems to be linked with fruit flies reward system, was strongly predictive of whether the flies drank. NPF was low in sexually frustrated flies lower in flies that had been isolated than in those that had company in their misery which appeared to drive them to drink.

Both mating and drinking alcohol increased NPF levels. Moreover, when NPF levels were artificially reduced in mated flies, they continued to show an extra preference for alcohol just as if they hadnt mated. These data suggest that activity of the NPF system is regulated by at least two rewarding experiences, mating and [alcohol] intoxication, the authors write.

The researchers also found that activating the NPF system was itself pleasurable to the flies, suggesting that it may create the feeling of satisfaction associated with drinking and sex.

Go here to see the original:
Bizarre Science: Sexually Frustrated Flies Are Driven to Drink

Stoughton police chief set to return after FBI training

The towns police chief is headed home after an extended training session with the FBI.

Police Chief Paul Shastany wrapped up 21/2 months at the invitation-only FBI National Academy in Quantico, Va. He will be back on the job Monday.

Classes at the academy include law, behavioral science, forensic science, understanding terrorism/terrorist mind sets, leadership development, communication and health/fitness. The academy has existed since 1935.

Executive Officer Robert Devine, who has been serving as acting chief in Shastanys absence, called it a momentous day in an email.

This is a huge occasion for all of us, and we couldnt be prouder of him, Devine wrote.

Shastany has been writing periodic updates on the training, posted on the departments Facebook page.

I cannot tell you how great this experience has been. I have many new friends, he wrote in his most recent post. We have come together as a team and will leave as individuals.

Shastany said he was inspired by the fellow law enforcement professionals he met during the training, including a New Jersey state police captain and a colonel in the Egyptian police force.

This experience was not so much about academics but rather about the character and commitment of the people, he wrote. The world is a better place because of the type of people that come here and serve their communities.

Justin Graeber may be reached at jgraeber@enterprisenews.com or follow him on Twitter @justingraeber.

View post:
Stoughton police chief set to return after FBI training

Canadian researchers receive grant to test stem-cell therapy for septic shock

OTTAWA A team of Canadian researchers has been awarded $442,000 to test the world's first experimental stem-cell therapy aimed at patients who suffer from septic shock, a runaway infection of the bloodstream that's notoriously difficult to treat.

The federal grant will allow researchers from the Ottawa Hospital Research Institute to use mesenchymal stem cells, found in the bone marrow of healthy adults, to treat as many as 15 patients with septic shock.

The deadly infection occurs when toxic bacteria spreads rapidly throughout the body and over-activates the immune system, leading to multiple organ failure and death in up to 40 per cent of cases.

One in five patients admitted to intensive-care units suffers from septic shock, making it the most common illness among a hospital's sickest of the sick.

Existing treatments focus on early diagnosis and intervention before organs start to fail. Patients with septic shock require aggressive resuscitation measures, large doses of intravenous antibiotics and, often, ventilators to help them breathe.

Yet because the infection can creep up on patients rapidly and cause unpredictable complications, death from septic shock remains relatively common.

The experimental therapy aims to use donor stem cells, grown and purified at the Ottawa laboratory, to dial down the body's hyperactive immune response and reduce the cascade of inflammation that leads to organ failure.

Early results from animal studies even raise the possibility that mesenchymal cells could eliminate the bacteria that causes septic shock, although the impact on humans is not yet known.

"It's a unique feature of the stem cells," said Dr. Lauralyn McIntyre, the intensive-care physician who is leading the trial. "Certainly no other therapy in the past, other than antibiotics, has impacted the bacterial load in the system."

As with other stem cells, mesenchymal cells can turn into a variety of more specialized cells and tissues that help repair and regenerate damaged organs. And because mesenchymal cells are derived from adults, they sidestep the ethical issues arising from the destruction of human embryos needed to make embryonic stem cells.

Continue reading here:
Canadian researchers receive grant to test stem-cell therapy for septic shock

Schumi launches women’s scholarship

Diversity ... Michael Schumacher wants to see more women racing in Formula 1. Source: Rob Griffith / AP

Michael Schumacher has helped launch a CAMS-funded Women of Australian Motorsport scholarship aimed at improving the odds for women competing in racing during a luncheon in Melbourne.

And the former Formula 1 champion says women have no physical barriers to competing at the top level.

"There is no reason why women should not be competitive in any of those fields that we have available in motor sport because physical limits - even in F1 - they're not so high that women couldn't do it," Schumacher said.

"I mean if you look at the athletics I'm pretty sure there are a few women who are fitter than I am.

"The main issue, why we don't see so many, is in the early days when you start to prepare to become a racing driver, it's a very small percentage of women doing it.

"That's why in the end, developing to the final stage, there is a left over chance of very little and I think this is the principal issue."

The recipient of the scholarship will be selected by a committee consisting of Steven Richards, and Women of Australian Motor Sport committee members Leanne Tander and Sue Evans.

Tander is the wife of V8 Supercars driver Garth Tander and a successful racer in her own right. She is also Australia's delegate to the FIA's Women and Motor Sport Commission.

Catch all the Formula 1 action with out weekend-long LIVE BLOG of the Australian Grand Prix.

More here:
Schumi launches women's scholarship

Update on our Contest! [Life Lines]

Thanks to all those who have been sending their ideas about why they like comparative physiology. Two non-science students sent me a list this week with the reasons they think comparative physiology is interesting. Do they deserve a Dolittle t-shirt? At least for "originality"?

Let me know what you think. Will post the update next week.

To try your chance at a FREE "What's new in comparative physiology" t-shirt just in time for Experimental Biology 2012, send Dr. Dolittle your reasons for enjoying comparative physiology. Be sure to also tell Dr. Dolittle what you are most looking forward to at the meeting. A new winner will be chosen every week prior to EB! If you are caught wearing Dr. Dolittle promotional items (official or homemade) at the meeting, you just may win a $10 Starbucks gift card! Just remember, the item MUST say either: "Dr. Dolittle", "Life Lines", or "comparative physiology".

To enter, send your reasons to Dr. Dolittle at drdlttl01@gmail.com

Good luck everyone! I look forward to hearing your ideas about why you like comparative physiology.

Continued here:
Update on our Contest! [Life Lines]

It's a Family Affair: BeSmartBeWell.com Recognizes National Nutrition Month With Tips to Help Families Eat Healthier

CHICAGO, March 15, 2012 /PRNewswire/ -- With about one out of every three children in this country obese or overweight, it's more important than ever to focus on healthy choices and changes that families can make together. Throughout March, which is National Nutrition Month, BeSmartBeWell.com shares stories of real families like Cindy and her children, who got healthier by cutting out junk food and exercising more.

To view the multimedia assets associated with this release, please visit: http://multivu.prnewswire.com/mnr/childhoodobesity/50831/

(Logo: http://photos.prnewswire.com/prnh/20120315/MM69985LOGO)

"We lost over 200 pounds together as a family," says Cindy in a video on Be Smart. Be Well. "After going back through and looking at pictures of where we were to where we've come, it's just absolutely amazing!"

Making changes for the betterParents don't have to do it all on their own. There are many resources available, including MyPlate by the USDA. In 2011, the USDA shed the traditional food pyramid for the new MyPlate, which illustrates the proper mix of fruit, vegetables, dairy, grains and protein you should eat to maintain a healthy diet. For example, it shows that a meal plate should be at least half filled with fruits and vegetables. Parents can use MyPlate to teach their kids what to put on their plate to make a healthy meal.

At BeSmartBeWell.com, Cindy demonstrates how she uses MyPlate in her own kitchen for her family's meals. "The only thing that goes on the table with us is vegetables. If they've had their portion of meat, bread or potato and they're still hungry, I say, 'there's still a whole bowl of vegetables there, eat them up,'" she says.

Cindy's son, Austin, says the changes the family made were big ones, but not difficult. Once his mom explained the dangerous path their diets had put them on, Austin made it his goal to eat right and get healthy. As he shed pounds, he also gained energy and confidence

"I want to live to be like 100 and do a ton of things. I want to travel to Paris! I want to go to Italy!" he says in a video on the site.

What can I do about it?BeSmartBeWell.com/Childhood-Obesity provides practical information to help families adopt healthy eating and exercise habits. Produced by the country's largest customer-owned health insurer, in collaboration with medical experts and national health organizations, BeSmartBeWell.com features:

At the site, visitors can also register for the monthly Spotlight Newsletter and News Alerts for in-depth articles and breaking news on nutrition, childhood obesity and other important health topics.

Visit link:
It's a Family Affair: BeSmartBeWell.com Recognizes National Nutrition Month With Tips to Help Families Eat Healthier

Local dietician celebrates nutrition month

Select a Publication: N E W S P A P E R S ---------------------------------------------- ---Alberta--- Airdrie - Airdrie Echo Banff - Banff Crag and Canyon Beaumont - Beaumont News Calgary - The Calgary Sun Camrose - Camrose Canadian Canmore - Canmore Leader Central Alberta - County Market Cochrane - Cochrane Times Cold Lake - Cold Lake Sun Crowsnest Pass - Crowsnest Pass Promoter Devon - Dispatch News Drayton - Drayton Valley Western Review Edmonton - Edmonton Examiner Edmonton - The Edmonton Sun Edson - Edson Leader Fairview - Fairview Post Fort McMurray - Fort McMurray Today Fort Saskatchewan - Fort Saskatchewan Record Grande Prairie - Daily Herald Tribune Hanna - Hanna Herald High River - High River Times Hinton - Hinton Parklander Lacombe - Lacombe Globe Leduc - Leduc Representative Lloydminster - Meridian Booster Mayerthorpe - Mayerthorpe Freelancer Nanton - Nanton News Peace Country - Peace Country Sun Peace River - Peace River Record Gazette Pincher Creek - Pincher Creek Echo Sherwood Park - Sherwood Park News Spruce Grove - Spruce Grove Examiner Stony Plain - Stony Plain Reporter Strathmore - Strathmore Standard Vermilion - Vermilion Standard Vulcan - Vulcan Advocate Wetaskiwin - Wetaskiwin Times Whitecourt - Whitecourt Star ---Manitoba--- Altona - Alton Red River Valley Echo Beausejour - Beausejour Review Carman - Carman Valley Leader Gimli - Interlake Spectator Lac Du Bonnet - Lac Du Bonnet Leader Morden - Morden Times Portage la Prairie - Portage Daily Graphic Selkirk - Selkirk Journal Stonewall - Stonewall Argus and Teulon Times Winkler - Winkler Times Winnipeg - The Winnipeg Sun ---Ontario--- Amherstburg - Amherstburg Echo Bancroft - Bancroft this Week Barrie - Barrie Examiner Barry's Bay - Barry's Bay this Week Belleville - Intelligencer Bradford - Bradford Times Brantford - Expositor Brockville - The Recorder & Times Chatham - Chatham Daily News Chatham - Chatham This Week Chatham - Today's Farmer Clinton - Clinton News-Record Cobourg - Northumberland Today Cochrane - Cochrane Times Post Collingwood - Enterprise Bulletin Cornwall - Standard Freeholder Delhi - Delhi News-Record Dresden - Leader Spirit Dunnville - Dunnville Chronicle Elliot Lake - Standard Espanola - Mid-North Monitor Fort Erie - Times Gananoque - Gananoque Reporter Goderich - Goderich Signal-Star Grand Bend - Lakeshore Advance Haliburton - Haliburton Echo Hanover - The Post Ingersoll - Ingersoll Times Innisfil - Innisfil Examiner Kapuskasing - Kapuskasing Northern Times Kenora - Kenora Daily Miner and News Kenora - Lake of the Woods Enterprise Kincardine - Kincardine News Kingston - Frontenac This Week Kingston - Kingston This Week Kingston - Kingston Whig Standard Kirkland Lake - Northern News Leamington - Leamington Post Lindsay - The Lindsay Post London - The London Free Press London - The Londoner Lucknow - Lucknow Sentinel Midland - Free Press Minden - Minden Times Mitchell - Mitchell Advocate Napanee - Napanee Guide Niagara-on-the-Lake - Niagara Advance Niagara Falls - Review Niagara Falls - Niagara Shopping News Niagara Falls - W. Niagara Community Newspapers North Bay - North Bay Nugget Northumberland - Northumberland Today Norwich - Norwich Gazette Orillia - Packet and Times Ottawa - The Ottawa Sun Owen Sound - Sun Times Oxford - Oxford Review Paris - Paris Star Online Pelham - Pelham News Pembroke - Daily Observer Peterborough - Peterborough Examiner Petrolia - Petrolia Topic Picton - County Weekly News Port Colborne - Inport News Port Hope - Northumberland Today Port Elgin - Shoreline Beacon Sarnia - Observer Sarnia - Sarnia This Week Sault Ste Marie - Sault Star Sault Ste Marie - Sault This Week Seaforth - Seaforth Huron Expositor Simcoe - Simcoe Reformer St. Catharines - St. Catharines Shopping News St. Catharines - Standard St. Thomas - St. Thomas Times-Journal Stirling - Community Press Stratford - The Beacon Herald Strathroy - Strathroy Age Dispatch Sudbury - Sudbury Star Thorold - Thorold News Tillsonburg - Tillsonburg News Timmins - Daily Press Timmins - Timmins Times Toronto - The Toronto Sun Trenton - Trentonian Wallaceburg - Wallaceburg Courier Press Welland - Tribune Welland - Welland News West Lorne - The Chronicle Wiarton - Wiarton Echo Woodstock - Sentinel Review ---Saskatchewan--- Meadow Lake - Meadow Lake Progress Melfort - Melfort Journal Nipawin - Nipawin Journal MAGAZINES & SPECIALTY PUBLICATIONS --------- Biz Magazine Business London Cottage Home and Property Showcase Food and Wine Show Hamilton Halton Weddings Hamilton Magazine InterVin International Wine Awards Kingston Life London Citylife Muskoka Magazine Muskoka Trails Niagara Food and Wine Expo Niagara Magazine Ontario Farmer Ontario Golf Sault Good Life Simcoe Life Sudbury Bride Guide The Home Show Vines Magazine What's Up Muskoka

See the original post:
Local dietician celebrates nutrition month

Gallery: Addressing four common nutrition myths

Myth: You have to drink eight cups of water per day

You hear it so often that eight cups of water a day is necessary for everything from weight control to cleansing the body that it seems it must be truth, but the reality is there is no good evidence to support this claim. In fact, this age-old myth is believed to have originally stemmed from a 1970s textbook that made the statement that the human body needs a bit more than two litres (8 cups) of fluid per day from all sources, including coffee, tea, milk, juice, pop and, yes, even alcohol. While we have sadly learned since then that alcohol is not good for hydration, we do know that virtually all fluids do hydrate us, including caffeinated drinks such as tea and coffee, so long as you are habituated to them. When it comes to weight, remember some drinks, such as pop and juice, contain quite a few calories, so sticking to water is usually best. Some individuals, including athletes, those at risk for kidney stones, and pregnant and breastfeeding women, might require extra fluids, but for everyone else, it's all about finding the right amount of fluids for you.

More here:
Gallery: Addressing four common nutrition myths

Mead Johnson Nutrition and SanCor Complete Joint Venture

BUENOS AIRES, Argentina & GLENVIEW, Ill.--(BUSINESS WIRE)--

Kasper Jakobsen, Mead Johnson Nutritions Chief Operating Officer (NYSE: MJN - News) and Oscar Carreras, Chairman of Board of Administration for SanCor Cooperativas Unidas Ltda. of Argentina, met today in Buenos Aires to officially establish a joint venture that will expand the availability of high-quality pediatric nutrition products across the Southern Cone of South America.

The venture unites a global leader in infant formula and pediatric nutrition with the leading dairy producer in Argentina for the benefit of infants and children across the region.

The new joint venture will develop, produce and market innovative pediatric nutritional products under the SanCor Beb brand, which holds the leading position in the Argentine market. The business and the brand will benefit from the potent combination of the two companies expertise. Mead Johnson will provide clinical research, proprietary formulas and product innovation excellence, while SanCor will contribute its deep local market knowledge and high-quality manufacturing capabilities.

Everybody wins with this transaction. Mead Johnson strengthens its presence and growth potential in South America, while SanCor is able to better leverage its outstanding manufacturing base and continue exploration of business opportunities in other promising categories, stated Oscar Carreras. More importantly, parents win with greater access to best-in-class products they can feed their children with confidence.

Mead Johnson will invest 850 million Argentine pesos (approximately US$196 million*) for an 80 percent ownership interest in the joint venture. In 2011, SanCors turnover in the infant formula and childrens growing-up milk categories totaled nearly 300 million pesos (approximately US$69 million*).

We appreciate SanCors leadership. SanCors manufacturing expertise is recognized globally and they have established Beb as the number one brand in Argentina, commented Kasper Jakobsen. We are excited about the potential for this venture to accelerate our growth in these key markets and to benefit local babies and children.

The joint venture will continue to produce its products at existing SanCor facilities in Argentina.

Beginning with first quarter 2012 reporting, Mead Johnson will consolidate the joint venture into its overall financial statements. The transaction is not expected to have any material impact on the companys 2012 earnings, as additional investment in the business, along with interest expense for the deal, will offset any first-year contribution from the venture.

* at current exchange rates

Read more here:
Mead Johnson Nutrition and SanCor Complete Joint Venture

Palestinians ask Israeli court to halt DNA tests

The Palestinian Authority has asked Israel's highest court to halt the taking of DNA samples from Palestinian prisoners against their will, a PA minister said on Thursday.

"We petitioned the Israeli Supreme Court yesterday against the humiliating treatment of our prisoners," prisoner affairs minister Issa Qaraqaa told a news conference in the West Bank city of Ramallah.

He said that at Shita prison in northern Israel, which holds mainly Palestinian security prisoners, inmates were forcibly restrained while samples of hair were taken and their mouths swabbed.

"These actions are illegal and contrary to all international standards, including medical ethics, and violate the privacy of prisoners," he said. "We have asked the World Health Organisation to issue a statement condemning these actions."

Israeli police spokesman Micky Rosenfeld said a campaign was underway to collect samples from all convicted prisoners in Israeli jails, both Jews and Arabs, regardless of the nature of their offences.

"In order to expand the database of DNA and forensics at the Israeli national police headquarters, at the moment we're in the process of taking DNA from prisoners, people who have already been convicted of crimes and who are serving time in jail," he told AFP.

"It's a new policy which is being implemented throughout the year 2012. It's beginning to be implemented now," he said. "It applies to all people who have been convicted."

"The process is taking place among all the different prisoners no matter what they've been convicted for."

He said that among those from whom a sample would be taken was Israel's former president Moshe Katsav, serving a seven-year prison sentence for rape, who has refused to give a sample voluntarily.

Local media said that in such cases, a court order could be sought to force compliance.

View post:
Palestinians ask Israeli court to halt DNA tests

Posted in DNA

DNA database: Authorities hope it will discourage crimes

Now that something as simple as shoplifting can get your DNA put in a statewide database forever, local authorities hope this will discourage people from committing crimes in the first place.

State legislators early Thursday morning passed a bill that doubles the state's DNA databank to now include genetic information from anyone convicted of any felonies and nearly any penal law misdemeanors. Previously, DNA was collected only from 48 percent of offenders convicted of penal law crimes.

One reason this expanded database will be a key tool for police is the reality that people who commit crimes in the past tend to commit more crimes in the future, officials said.

By broadening the number of crimes that can result in a person's DNA being put on file, that increases the odds of finding a match if that person leaves behind the slightest genetic evidence while committing another crime, especially burglaries and sex crimes.

We've already solved a lot of cases this way, and this absolutely opens the range of people who will be in the database, Utica police Chief Mark Williams said. So, it's more likely we'll be able to solve crimes more quickly.

This DNA databank also might help investigators quickly determine whether they have the right or wrong suspect, lessening the odds of a wrongful conviction. But authorities also hope this will make criminals think twice about breaking the law again.

Oneida County District Attorney Scott McNamara said, There's part of me that hopes this will make our communities safer because it will have a deterrent effect on people committing crimes by making them say, 'Hey, they have my DNA on file, and if I leave any DNA behind now they're going to be able to find out who I am.'

This legislation also will give defendants more access to DNA testing before trial to demonstrate their innocence, or give them limited access to certain evidence after trial based on credible allegations.

View original post here:
DNA database: Authorities hope it will discourage crimes

Posted in DNA

N.Y. Passes DNA Requirement For Convicted Criminals

Enlarge Mike Groll/AP

A forensic scientist processes DNA samples at the New York State Police lab in Albany.

A forensic scientist processes DNA samples at the New York State Police lab in Albany.

Early on Thursday, lawmakers in New York approved a bill that will make the state the first to require DNA samples from almost all convicted criminals and make its DNA database one of the largest in the nation.

Most states, including New York, already collect DNA samples from felons, according to the National Conference of State Legislatures. What's remarkable about the New York bill is that it would expand the state's database to include DNA from people convicted of almost any crime, even misdemeanors as minor as jumping over a subway turnstile.

Donna Lieberman, director of the New York Civil Liberties Union, is concerned the strain of all that additional DNA will overwhelm the state crime labs that handle it.

"Instead of helping us solve crimes, this may result in the conviction of innocent New Yorkers," she says. "What we've seen in other jurisdictions is that when you engage in the massive expansion of the database like that, there are shortcuts that are taken and there's negligence, there's fraud, there's contamination. And it's really an enormous hurdle for defendants."

The bill's authors did exempt minor marijuana convictions from the DNA reporting requirement. But its backers, including Richard Aborn at the Citizens Crime Commission of New York City, say there's a good argument for including even the most minor offenses in the database.

"We know from lots of studies and lots of data now that violent criminals very often begin their careers as nonviolent criminals," Aborn says. "And the earlier you can get a nonviolent criminal's DNA in the data bank, the higher your chances are of apprehending the right person."

That may be why the bill has enjoyed the support of district attorneys all across the state. Aborn says the bill's authors did a good job of making sure that defense lawyers will have access to the database, too. And he points out that DNA can be used to prove innocence, as well as guilt.

Read more from the original source:
N.Y. Passes DNA Requirement For Convicted Criminals

Posted in DNA

This is Carolina Biology

Yes thats right, the famous segment often shown in the Dean Dome has taken on a new form the biology department has created its own version of the I am a Tar Heel video.

Kelly Hogan, a senior lecturer in the biology department, is the mastermind behind the video. She said she got the idea one day when she saw the original video in the Dean Dome with her husband, Brian Hogan, who is also a member of the faculty at UNC.

Its a powerful video, and the students especially love it. We envisioned a silly scenario of students going wild if professors were on the big screen at the game, Kelly Hogan said.

Kelly Hogans purpose with the video was to provide a sense of community, and show the students that the professors can have a bit of fun.

She intends to show the video at the departmental graduation ceremony in May.

She said that while the students might not go crazy when they see their professors on the board, it will give the students a little something to remember.

With the NCAA Tournament going on, students tend to pull a few sick days to watch basketball, but professors are just as excited about March Madness as we are.

Gregory Copenhaver, an associate professor in the biology department, said that the department has so much school spirit that they have to mop it off the floors.

Im pretty sure that our devotion to college basketball is so passionate that if we tried we would be eligible for tax-free status as a religion, Copenhaver said.

Jean Desaix, another senior lecturer in the biology department, reiterated the same sentiment.

Visit link:
This is Carolina Biology

Ex-head of behavioral science at MeritCare in Fargo gets 120 days for window peeping

CLOQUET, Minn. The former head of behavioral health at Fargos MeritCare was sentenced to 120 days in jail on Wednesday after he was caught peeping here at the window of the juvenile daughter of his neighbor last summer.

Richard Allen Paul, 57, of Cloquet, had pleaded guilty in December to a felony interference with privacy charge and was sentenced Wednesday in Carlton County District Court in front of his victims, other neighbors and his own family. The charge is a felony because the person whose privacy was violated was a minor.

Paul, who was director of behavior services for Essentia Health System in Duluth before he was arrested and held a similar position at the predecessor to Sanford Health in Fargo from 1999 to 2002, apologized in the courtroom.

Not a day goes by that I dont regret my actions, Paul said. Not a day goes by that I dont pray for (the vicitms family) that God gives them relief from the pain I gave to them.

B.J. Berg discovered Paul outside Bergs home at 11:30 p.m. on June 14, 2011, wearing a black ski mask, tan shirt and jeans while peering into a bedroom window. When Berg confronted him, Paul said something about trying to find his dogs.

Berg told him, Not at my daughters window, youre not, and told him to get off his property.

Berg followed Paul to his home and called the police, who searched Pauls home and found night vision goggles, a ski mask, clothing and a loaded handgun. Paul admitted to police he had a firearm on his hip while outside Bergs home.

In his statement in court, Berg talked about the close-knit nature of their rural Cloquet neighborhood 20 miles west of Duluth and how Paul built trust with his neighbors and their children over 12 years.

This whole ordeal has been a sad lesson for our kids and family to learn that you may not be able to trust the people you have grown to respect, and that your home may not be the safe haven you thought it was, Berg told the court, adding that his children havent ventured down the road on their bikes to visit friends since then. Some of their childhood innocence has been lost and their perception of safety in our home has been diminished.

Paul sat with his head down during most of Bergs statement.

Read more:
Ex-head of behavioral science at MeritCare in Fargo gets 120 days for window peeping

Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock

Public release date: 15-Mar-2012 [ | E-mail | Share ]

Contact: Jennifer Ganton jganton@ohri.ca 613-798-5555 x73325 Ottawa Hospital Research Institute

A team of researchers from the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa (uOttawa) has been awarded $367,000 from the Canadian Institutes of Health Research (CIHR) and $75,000 from the Stem Cell Network to lead the first clinical trial in the world of a stem cell therapy for septic shock. This deadly condition occurs when an infection spreads throughout the body and over-activates the immune system, resulting in severe organ damage and death in 30 to 40 per cent of cases. Septic shock accounts for 20 per cent of all Intensive Care Unit (ICU) admissions in Canada and costs $4 billion annually. Under the leadership of Dr. Lauralyn McIntyre, this new "Phase I" trial will test the experimental therapy in up to 15 patients with septic shock at The Ottawa Hospital's ICU.

The treatment involves mesenchymal stem cells, also called mesenchymal stromal cells or MSCs. Like other stem cells, they can give rise to a variety of more specialized cells and tissues and can help repair and regenerate damaged organs. They also have a unique ability to modify the body's immune response and enhance the clearance of infectious organisms. They can be found in adult bone marrow and other tissues, as well as umbilical cord blood, and they seem to be easily transplantable between people, because they are more able to avoid immune rejection.

There has been a great deal of interest in using MSCs to treat disease, with most research so far focused on heart disease, stroke, inflammatory bowel disease and blood cancers. Hundreds of patients with these diseases have already been treated with MSCs through clinical trials, with results suggesting that these cells are safe in these patients, and have promising signs of effectiveness. MSCs are still considered experimental however, and have not been approved by Health Canada as a standard therapy for any disease.

In recent years, a number of animal studies have suggested that MSCs may also be able to help treat septic shock. For example, a recent study by Dr. Duncan Stewart, CEO and Scientific Director of OHRI (and also a co-investigator on the new clinical trial) showed that treatment with these cells can triple survival in a mouse model of this condition.

"Mesenchymal stem cell therapy appears promising in animal studies, but it will require many years of clinical trials involving hundreds of patients to know if it is safe and effective," said Dr. Lauralyn McIntyre, a Scientist at the OHRI, ICU Physician at The Ottawa Hospital, Assistant Professor of Medicine at uOttawa and a New Investigator with CIHR and Canadian Blood Services. "This trial is a first step, but it is a very exciting first step."

As with all "Phase I" trials, the main goal of this study is to evaluate the safety of the therapy and determine the best dose for future studies. The 15 patients in the treatment group will receive standard treatments (such as fluids, antibiotics and blood pressure control), plus a planned intravenous dose of 0.3 to 3 million MSCs per kg of body weight. The MSCs will be obtained from the bone marrow of healthy donors and purified in the OHRI's Good Manufacturing Practice Laboratory in the Sprott Centre for Stem Cell Research. The researchers also plan to evaluate 24 similar septic shock patients who will receive standard treatments only (no MSCs). All patients will be rigorously monitored for side effects, and blood samples will be taken at specific time points to monitor the cells and their activity. This trial will not be randomized or blinded and it will not include enough patients to reliably determine if the therapy is effective. It will be conducted under the supervision of Health Canada and the Ottawa Hospital Research Ethics Board, and will have to be approved by both of these organizations before commencing.

"The OHRI is rapidly becoming known as a leader in conducting world-first clinical trials with innovative therapies such as stem cells," said Dr. Duncan Stewart, CEO and Scientific Director of OHRI, Vice-President of Research at The Ottawa Hospital and Professor of Medicine at uOttawa. "This research is truly pushing the boundaries of medical science forward, and is providing the citizens of Ottawa with access to promising new therapies."

"The Canadian Institutes of Health Research (CIHR) is very pleased to support this clinical trial," said Dr. Jean Rouleau, Scientific Director of the CIHR Institute of Circulatory and Respiratory Health. "The work of Dr. McIntyre and her colleagues will not only add to our growing knowledge of the benefits of stem-cell therapies, but will hopefully lead to treatments that can help save the lives of patients where currently, our treatment options are less than optimal."

Read the original post:
Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock

Bioheart and Ageless Partner to Advance Stem Cell Field With Laboratory Training Programs

SUNRISE, Fla., March 15, 2012 (GLOBE NEWSWIRE) -- Bioheart, Inc. (BHRT.OB) announced today that it has successfully conducted a laboratory training course in partnership with the Ageless Regenerative Institute, an organization dedicated to the standardization of cell regenerative medicine. The attendees participated in hands on, in depth training in laboratory practices in stem cell science.

"We had students from all over the world attend this first course including physicians, laboratory technicians and students," said Mike Tomas, Bioheart's President and CEO. "Bioheart is pleased to be able to share our 13 years of experience in stem cell research and help expand this growing life science field."

The course included cell culture techniques and quality control testing such as flow cytometry and gram stain. In addition, participants learned how to work in a cleanroom operating according to FDA cGMP standards, regulations used in the manufacture of pharmaceuticals, food and medical devices. Aseptic techniques were also taught as well as cleanroom gowning, environmental monitoring and maintenance.

Future courses are open to physicians, laboratory technicians and students. After graduating the course, attendees are prepared to pursue research and careers in the field of stem cells and regenerative medicine. For more information about the course, contact info@agelessregen.com.

About Bioheart, Inc.

Bioheart is committed to maintaining its leading position within the cardiovascular sector of the cell technology industry delivering cell therapies and biologics that help address congestive heart failure, lower limb ischemia, chronic heart ischemia, acute myocardial infarctions and other issues. Bioheart's goals are to cause damaged tissue to be regenerated, when possible, and to improve a patient's quality of life and reduce health care costs and hospitalizations.

Specific to biotechnology, Bioheart is focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage and peripheral vascular disease. Its leading product, MyoCell, is a clinical muscle-derived cell therapy designed to populate regions of scar tissue within a patient's heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients. For more information on Bioheart, visit http://www.bioheartinc.com.

About Ageless Regenerative Institute, LLC

The Ageless Regenerative Institute (ARI) is an organization dedicated to the standardization of cell regenerative medicine. The Institute promotes the development of evidence-based standards of excellence in the therapeutic use of adipose-derived stem cells through education, advocacy, and research. ARI has a highly experienced management team with experience in setting up full scale cGMP stem cell manufacturing facilities, stem cell product development & enhancement, developing point-of-care cell production systems, developing culture expanded stem cell production systems, FDA compliance, directing clinical & preclinical studies with multiple cell types for multiple indications, and more. ARI has successfully treated hundreds of patients utilizing these cellular therapies demonstrating both safety and efficacy. For more information about regenerative medicine please visit http://www.agelessregen.com.

Forward-Looking Statements: Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "to," "plan," "expect," "believe," "anticipate," "intend," "could," "would," "estimate," or "continue" or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements.

Read more here:
Bioheart and Ageless Partner to Advance Stem Cell Field With Laboratory Training Programs

Washington Center for Pain Management Begins Enrollment in United States Stem Cell Therapy Study in Subjects With …

EDMONDS, Wash., March 14, 2012 /PRNewswire/ --Washington Center for Pain Management is participating in a nationwide FDA-cleared adult stem cell study testing novel treatment for chronic low back pain and has enrolled its first patient. The study will test the use of Mesenchymal Precursor Cells (MPCs) adult stem cells derived from bone marrow that will be directly injected into the lumbar disc. The minimally invasive procedure may offer an alternative to back surgery for eligible patients with chronic pain from degenerative discs.

An estimated 30 million people in the United States suffer from back pain. Degenerative disc disease is the most common cause of low-back pain, which develops with the gradual loss of a material called proteoglycan, which cushions the bones of the spine and enables normal motion.

Most patients with low-back pain respond to physical therapy and medications, but in advanced cases, artificial disc replacement or spinal fusion -- removal of the degenerated discs and the fusion of the bones of the spine -- is necessary. However, these surgeries often are not entirely effective.

"Millions of Americans are debilitated by chronic low back pain," says Dr Hyun Joong Hong MD, the lead investigator at The Washington Center for Pain Management. "This promising therapy is at the cutting edge of medical science and has the potential to create a paradigm shift in our approach to minimally invasive solutions to this disease."

Researchers will enroll approximately 100 study participants. About fifteen participants will be enrolled at The Washington Center for Pain Management and the rest at 11 other medical centers throughout the United States. The trial is scheduled to last for three years.

Washington Center for Pain Management is enrolling study participants suffering from moderate low-back pain for a minimum of six months and whose condition has not responded to other, conventional treatments.

Once enrolled, patients are randomly assigned to one of four treatment groups:

Patients will receive a single injection of their assigned test agent directly into the center of the target discs within their spine and will be monitored for safety. Patients will also be monitored using imaging to identify any changes in their disease condition or disease progression. Use of pain medications, self-reports of pain, subsequent surgical interventions and assessments of disability, quality of life, productivity and activity will be evaluated. Repair of the disc and reduction of chronic back pain will be assessed in each patient.

Promising results have been observed in prior research using animal models when stem cells were investigated for the repair of damaged spine discs. The cells were well tolerated in these study animals.

This study is sponsored by Mesoblast Limited, a world leader in the development of biologic products for the broad field of regenerative medicine. Mesoblast has the worldwide exclusive rights to a series of patents and technologies developed over more than 10 years relating to the identification, extraction, culture and uses of adult Mesenchymal Precursor Cells (MPCs). The MPCs are derived from young adult donors' bone marrow and are immune tolerant.

See original here:
Washington Center for Pain Management Begins Enrollment in United States Stem Cell Therapy Study in Subjects With ...

Ottawa researchers receive grant to test stem-cell therapy for septic shock

OTTAWA A team of Ottawa researchers has been awarded $442,000 to test the worlds first experimental stem-cell therapy aimed at patients who suffer from septic shock, a runaway infection of the bloodstream thats notoriously difficult to treat.

The federal grant will allow researchers from the Ottawa Hospital Research Institute to use mesenchymal stem cells, found in the bone marrow of healthy adults, to treat as many as 15 patients with septic shock.

The deadly infection occurs when toxic bacteria spreads rapidly throughout the body and over-activates the immune system, leading to multiple organ failure and death in up to 40 per cent of cases.

One in five patients admitted to intensive-care units suffers from septic shock, making it the most common illness among a hospitals sickest of the sick.

Existing treatments focus on early diagnosis and intervention before organs start to fail. Patients with septic shock require aggressive resuscitation measures, large doses of intravenous antibiotics and, often, ventilators to help them breathe.

Yet because the infection can creep up on patients rapidly and cause unpredictable complications, death from septic shock remains relatively common.

The experimental therapy aims to use donor stem cells, grown and purified at the Ottawa laboratory, to dial down the bodys hyperactive immune response and reduce the cascade of inflammation that leads to organ failure.

Early results from animal studies even raise the possibility that mesenchymal cells could eliminate the bacteria that causes septic shock, although the impact on humans is not yet known.

Its a unique feature of the stem cells, said Dr. Lauralyn McIntyre, the intensive-care physician who is leading the trial. Certainly no other therapy in the past, other than antibiotics, has impacted the bacterial load in the system.

Like other stem cells, mesenchymal cells can turn into a variety of more specialized cells and tissues that help repair and regenerate damaged organs. And because mesenchymal cells are derived from adults, they sidestep the ethical issues arising from the destruction of human embryos needed to make embryonic stem cells.

See the rest here:
Ottawa researchers receive grant to test stem-cell therapy for septic shock

Amedisys Scores 19% Above National Average on Treatment Goals Met at Home

BATON ROUGE, La.--(BUSINESS WIRE)--

Amedisys, Inc. (NASDAQ: AMED - News) today announced it has proven clinical excellence with its Speech-Language Pathology (SLP) program, according to the American Speech-Language and Hearing Association (ASHA) National Outcomes Measurement System (NOMS) report for 2011.

Developed to illustrate the value of speech-language pathology services provided to people with swallowing disorders, cognitive and memory impairments, and communication disorders, NOMS is a data collection system, recognized by the Centers for Medicare and Medicaid Services (CMS). The key to NOMS is the use of ASHAs Functional Communication Measures (FCMs). FCMs are a series of disorder-specific seven-point rating scales, designed to describe the change in an individuals functional communication, swallowing, or cognitive/memory abilities over the course of treatment.

According to the 2011 NOMS data, Amedisys Speech-Language Pathology outcomes for treatment goals met in the home exceeded the national home care industry average by 19%. The national average for 2011 was 51.78% of treatment goals met in the home, while Amedisys met 70.87% of treatment goals.

We are extremely proud of our Speech-Language Pathology team here at Amedisys for achieving this level of high-quality care for our patients, said Jim Robinson, executive vice president of home health and hospice care for Amedisys. Our team of 600 speech-language pathologists, based in more than 300 Amedisys care centers across the country, work with thousands of patients each year to improve their communication skills and help with memory deficits. This specialized care often reduces the need for feeding tubes and helps patients recover the ability to swallow.

Swallowing disorders (also known as dysphagia) are diagnosed in approximately 10 million Americans each year. Nearly all dementia patients develop dysphagia, and swallowing disorders also are associated with stroke, respiratory conditions, brain and spinal cord injury, as well as progressive neurological conditions like multiple sclerosis, ALS and Parkinsons. People who suffer from swallowing disorders often experience weight loss, poor nutrition, dehydration, social isolation, choking and pneumonia.

In the last 10 years, the number of elderly Medicare beneficiaries who were admitted to the hospital for aspiration pneumonia increased by 93.8%, said David Hutchings, CCC-SLP.D., managing director of Rehab Services at Amedisys. Through our Speech Language Pathology program, our multidisciplinary care team takes a comprehensive approach in addressing dysphagia to help decrease the risk of aspiration pneumonia and hospitalizations for this condition.

To help those with swallowing disorders avoid health complications like pneumonia, Dr. Hutchings urges seniors and their loved ones to watch for, and talk to a health care professional about, the following symptoms:

By proactively treating swallowing disorders and using specialized feeding techniques that maintain nutritional needs, enhance safe food intake and maintain dignity for those on our home health and hospice service, we can help to reduce unnecessary hospitalizations, and improve peoples overall quality of life, Dr. Hutchings said.

For more information about NOMS, please visit: http://www.asha.org/members/research/noms/.

More here:
Amedisys Scores 19% Above National Average on Treatment Goals Met at Home

This Week in Clinical Pathology

Bristol researchers report their clinicopathological and molecular assessment of 12 penile melanoma cases in the Journal of Clinical Pathology. The researchers examined the paraffin-embedded, formalin-fixed tumor tissue for KIT and BRAF mutations, which are common in other melanomas, but found no such mutations. As for the clinicopathological features, the researchers say that two-year and five-year survival was, respectively, 61 percent and 20 percent, which is a similar prognosis as other melanomas. "Penile melanomas are extremely rare and have a similar prognosis to melanomas elsewhere, but they often present late, leading to a poor outcome. The mutations seen in melanomas from other sites appear to be rarely present in these tumors," the Bristol team concludes.

Also in the Journal of Clinical Pathology, German researchers look at p53, p21, and cyclin D1 expression in 110 penile cancer cases. From this, the researchers found that p53 expression in the primary tumor is associated with a poor outcome, while p21 expression had a minor impact on survival and cyclin D1 had no association. "The possible prognostic implications of p21 seem to be complex and warrant further investigation," the team says.

Continue reading here:
This Week in Clinical Pathology